A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

NCT00641082 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

HBeAg(-) Chronic Hepatitis B With Compensated Liver Function

Interventions

DRUG: Clevudine
DRUG: Adefovir dipivoxil

Sponsor

Bukwang Pharmaceutical